Improve walking while dual tasking
- Trial ID
- NCT06416722
- Official Title
- Multidimensional Evaluation of the Effectiveness of Telerehabilitation-Based Dual-Task Training in Parkinson's Patients
- Goal
- Improve walking while dual tasking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Fenerbahce University
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease
- Interventions
- Cognitive-Motor Dual Task Activities, Motor-Motor Dual Task Activities, Cognitive-Motor & Motor-Motor Dual Task Activities
Summary For Families
The goal is to help people with Parkinson's improve walking, balance, and the ability to do a second task at the same time, like talking or carrying something, so everyday multitasking causes fewer stumbles, freezes, and balance problems. The approach uses telerehabilitation to guide dual-task exercises that pair walking with cognitive tasks or a second motor task, training the brain and body to coordinate attention and movement better; sessions are done remotely via smartphone or computer and are meant to complement your usual Parkinson's medications rather than replace them. The study is enrolling 30 people aged 30 to 75 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk independently, are in their "On" period, have had stable medication for at least a month, and score 21 or higher on the MoCA. People with serious vision or hearing loss, other neurological, cardiovascular, or orthopedic conditions that affect walking, less than five years of education, vascular leg problems, or no internet access are not eligible.
Locations
- Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi, Istanbul, Bakırköy, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Cognitive-Motor Dual Task Activities. The goal is to help people with Parkinson's improve walking, balance, and the ability to do a second task at the same time, like talking or carrying something, so everyday multitasking causes fewer stumbles, freezes, and balance problems. The approach uses telerehabilitation to guide dual-task exercises that pair walking with cognitive tasks or a second motor task, training the brain and body to coordinate attention and movement better; sessions are done remotely via smartphone or computer and are meant to complement your usual Parkinson's medications rather than replace them. The study is enrolling 30 people aged 30 to 75 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk independently, are in their "On" period, have had stable medication for at least a month, and score 21 or higher on the MoCA. People with serious vision or hearing loss, other neurological, cardiovascular, or orthopedic conditions that affect walking, less than five years of education, vascular leg problems, or no internet access are not eligible.
- Who can participate?
- Participants must be between 30 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.